Sanofi-Aventis SA (SNY)

Add a New Bulls Reason Company: Sanofi-Aventis SA (SNY) Current price: Headline: (100 character max) Analysis: Cancel 90% agree 20 votes   Robust pipeline with over 125 drugs in development Top Contributor: Jason Young | Created when NYSE:SNY was $40.93 | Edit | History Sanofi-Aventis has a robust pipeline with over 125 drugs in development; 25 of these drugs are set to launch in the next 2 to four years which will provide a substantial boost to earnings. (100 character max) Cancel 100% agree 2 votes   Strong global franchise Top Contributor: Jason Young | Created when NYSE:SNY was $40.93 | Edit | History Sanofi-Aventis' strong global franchise will allow it to take full advantage of key demographic shifts such as aging populations in developed nations and the rising middle class in emerging markets. (100 character max) Cancel 100% agree 1 votes   First in class drugs Top Contributor: Sar Medoff | Created when NYSE:SNY was $39.97 | Edit | History Sanofi-Aventis has 40 drugs that are "first in class" which means that they are unique in their method of treatment. First in class in class drugs are particularly attractive because of their blockbuster potential. (100 character max) Cancel

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.